CSF TREM2 level was deranged at the early stage of AD, and it was closely related to neurodegenerative biomarkers such as T-tau and/or P-tau (Heslegrave et al., 2016; Suárez-Calvet et al., 2016b). Here, MAPT is linked to Alzheimer disease.